EGFR and neoplasm: For example, specific co-occuring genetic alterations acquired with disease progression (e.g. in CTNNB1 and PIK3CA), were shown to cooperatively promote tumor metastasis, while other evolutionary paths impair the apoptotic response and cause resistance to EGFR inhibitors [44, 45].